• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常压力脑积水患者脑脊液生物标志物与年龄相关脑改变的关系。

Association Between Cerebrospinal Fluid Biomarkers and Age-related Brain Changes in Patients with Normal Pressure Hydrocephalus.

机构信息

Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, 60 Leonard avenue, Toronto, ON, M5T 2S8, Canada.

Department of medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada.

出版信息

Sci Rep. 2020 Jun 4;10(1):9106. doi: 10.1038/s41598-020-66154-y.

DOI:10.1038/s41598-020-66154-y
PMID:32499567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7272629/
Abstract

Our study aimed to: 1)investigate the diagnostic utility of CSF Aβ42, t-tau, and p-tau to differentiate normal-pressure-hydrocephalus(NPH) from Alzheimer's-disease(AD) and normal-controls; and 2)investigate if age and ventricular size affect the levels of CSF biomarkers in NPH patients. We recruited 131 participants: (a)Suspected-NPH: 72 with ventriculomegaly and clinical symptoms of NPH. These participants were then divided into two groups of 1)Probable-NPH (N = 38) and 2)Unlikely-NPH (N = 34) based on whether participants experienced gait improvement after removal of a large amount of CSF; (b)AD group: 30 participants with CSF biomarkers and cognitive symptoms consistent with AD; (c)Control-group: 29 participants who were cognitively and functionally normal. Lower levels of CSF Aβ42 and p-tau were observed in the probable-NPH compared to the normal controls(444.22 ± 163.3 vs. 1213.75 ± 556.5; and 26.05 ± 9.2 vs. 46.16 ± 13.3 pg/mL; respectively). Lower levels of CSF p-tau and t-tau were found in the probable-NPH compared to the AD(26.05 ± 9.2 vs. 114.95 ± 28.2; and 193.29 ± 92.3 vs. 822.65 ± 311.5 pg/mL; respectively) but the CSF-Aβ42 was low in both the probable-NPH and AD. CSF-Aβ42 correlated with age and Evans-index only in the probable-NPH(r = 0.460, p = 0.004; and r = -0.530, p = 0.001; respectively). Our study supports the hypothesis that age-related atrophy results in better Aβ42 clearance in the CSF because of the increase in the interstitial space.

摘要

我们的研究旨在

1)探讨 CSF Aβ42、t-tau 和 p-tau 对正常压力脑积水(NPH)与阿尔茨海默病(AD)和正常对照的诊断效用;2)探讨年龄和脑室大小是否影响 NPH 患者 CSF 生物标志物的水平。我们招募了 131 名参与者:(a)疑似 NPH:72 名伴有脑室扩大和 NPH 临床症状。这些参与者随后根据是否在大量 CSF 清除后出现步态改善分为两组:1)可能的 NPH(N=38)和 2)不太可能的 NPH(N=34);(b)AD 组:30 名 CSF 生物标志物和认知症状符合 AD 的参与者;(c)对照组:29 名认知和功能正常的参与者。与正常对照组相比,可能的 NPH 中 CSF Aβ42 和 p-tau 的水平较低(444.22±163.3 与 1213.75±556.5;26.05±9.2 与 46.16±13.3 pg/mL;分别)。与 AD 相比,可能的 NPH 中 CSF p-tau 和 t-tau 的水平较低(26.05±9.2 与 114.95±28.2;193.29±92.3 与 822.65±311.5 pg/mL;分别),但 CSF-Aβ42 在可能的 NPH 和 AD 中均较低。CSF-Aβ42 仅与年龄和 Evans 指数在可能的 NPH 中相关(r=0.460,p=0.004;r=-0.530,p=0.001;分别)。我们的研究支持以下假说,即年龄相关萎缩导致 CSF 中 Aβ42 清除增加,从而导致 Aβ42 清除增加,这是由于间质空间增加所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aea/7272629/5e72542f51ae/41598_2020_66154_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aea/7272629/a98b989ffc40/41598_2020_66154_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aea/7272629/1a095abd563a/41598_2020_66154_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aea/7272629/ce25eb3f841b/41598_2020_66154_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aea/7272629/5e72542f51ae/41598_2020_66154_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aea/7272629/a98b989ffc40/41598_2020_66154_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aea/7272629/1a095abd563a/41598_2020_66154_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aea/7272629/ce25eb3f841b/41598_2020_66154_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aea/7272629/5e72542f51ae/41598_2020_66154_Fig4_HTML.jpg

相似文献

1
Association Between Cerebrospinal Fluid Biomarkers and Age-related Brain Changes in Patients with Normal Pressure Hydrocephalus.正常压力脑积水患者脑脊液生物标志物与年龄相关脑改变的关系。
Sci Rep. 2020 Jun 4;10(1):9106. doi: 10.1038/s41598-020-66154-y.
2
Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus.阿尔茨海默病脑脊液生物标志物在正常压力性脑积水患者中可能会产生误导。
Neurology. 2014 Oct 21;83(17):1573-5. doi: 10.1212/WNL.0000000000000916.
3
Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.脑脊液 Aβ42、t-tau 和 p-tau 水平在特发性正常压力脑积水鉴别诊断中的作用:系统评价和荟萃分析。
Fluids Barriers CNS. 2017 May 10;14(1):13. doi: 10.1186/s12987-017-0062-5.
4
Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.正常压力脑积水患者的脑脊液淀粉样蛋白β 42、总 tau 和磷酸化 tau 水平较低:与阿尔茨海默病的相似性和差异性。
J Alzheimers Dis. 2017;60(1):183-200. doi: 10.3233/JAD-170186.
5
Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.特发性正常压力脑积水与阿尔茨海默病及皮质下缺血性血管病的脑脊液生物标志物:一项系统评价
J Alzheimers Dis. 2019;68(1):267-279. doi: 10.3233/JAD-180816.
6
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.与临床前阿尔茨海默病核心 CSF 生物标志物相关的纵向结构脑变化:两项独立数据集研究。
Neuroimage Clin. 2018 Apr 16;19:190-201. doi: 10.1016/j.nicl.2018.04.016. eCollection 2018.
7
Alzheimer Disease Cerebrospinal Fluid Biomarkers in a Tertiary Neurology Practice.在一家三级神经科诊所的阿尔茨海默病脑脊液生物标志物。
Mayo Clin Proc. 2024 Aug;99(8):1284-1296. doi: 10.1016/j.mayocp.2023.12.024. Epub 2024 Jun 25.
8
Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.特发性正常压力脑积水的脑脊液生物标志物和脑活检结果
PLoS One. 2014 Mar 17;9(3):e91974. doi: 10.1371/journal.pone.0091974. eCollection 2014.
9
Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease.早期阿尔茨海默病中神经退行性变的脑脊液标志物与脑萎缩速度。
JAMA Neurol. 2015 Jun;72(6):656-65. doi: 10.1001/jamaneurol.2015.0202.
10
CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.脑脊液生物标志物可区分特发性正常压力脑积水与其类似疾病。
J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1117-1123. doi: 10.1136/jnnp-2019-320826. Epub 2019 Jun 5.

引用本文的文献

1
Distinct inflammatory profiles in young-onset versus late-onset Alzheimer's disease.早发型与晚发型阿尔茨海默病的不同炎症特征。
Alzheimers Dement. 2025 Jul;21(7):e70509. doi: 10.1002/alz.70509.
2
Postoperative changes in ventricular cerebrospinal fluid biomarkers with correlation to clinical outcome in idiopathic normal pressure hydrocephalus.特发性正常压力脑积水患者术后脑室脑脊液生物标志物的变化及其与临床结局的相关性
J Alzheimers Dis. 2025 Jun 20;106(3):13872877251350308. doi: 10.1177/13872877251350308.
3
A bibliometric analysis and visualization of normal pressure hydrocephalus.
正常压力脑积水的文献计量分析与可视化
Front Neurol. 2024 Jul 31;15:1442493. doi: 10.3389/fneur.2024.1442493. eCollection 2024.
4
Peripheral immunity changes are associated with neurodegeneration and worse clinical outcome in idiopathic normal pressure hydrocephalus.外周免疫变化与特发性正常压力脑积水的神经退行性变和更差的临床结局相关。
Eur J Neurol. 2024 Mar;31(3):e16179. doi: 10.1111/ene.16179. Epub 2023 Dec 21.
5
Charting the Next Road Map for CSF Biomarkers in Alzheimer's Disease and Related Dementias.绘制阿尔茨海默病和相关痴呆症中 CSF 生物标志物的下一个路线图。
Neurotherapeutics. 2023 Jul;20(4):955-974. doi: 10.1007/s13311-023-01370-8. Epub 2023 Jun 28.
6
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays.脑脊液脂蛋白通过与种子扩增试验中的寡聚体相互作用来抑制α-突触核蛋白聚集。
Mol Neurodegener. 2023 Apr 1;18(1):20. doi: 10.1186/s13024-023-00613-8.
7
Cerebrospinal Fluid Biomarkers in iNPH: A Narrative Review.正常压力脑积水的脑脊液生物标志物:一篇综述
Diagnostics (Basel). 2022 Nov 28;12(12):2976. doi: 10.3390/diagnostics12122976.
8
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus.特发性正常压力脑积水患者的阿尔茨海默病脑脊液生物标志物特征
J Pers Med. 2022 Jun 6;12(6):935. doi: 10.3390/jpm12060935.
9
CSF Biomarkers Predict Gait Outcomes in Idiopathic Normal Pressure Hydrocephalus.脑脊液生物标志物可预测特发性正常压力脑积水的步态结局。
Neurol Clin Pract. 2022 Apr;12(2):91-101. doi: 10.1212/CPJ.0000000000001156.
10
Reappraisal of Pediatric Normal-Pressure Hydrocephalus.小儿正常压力脑积水的重新评估
J Clin Med. 2021 May 9;10(9):2026. doi: 10.3390/jcm10092026.